IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Teva Pharmaceutical Finance Netherlands IV BV

Q3 2025 vs Q4 2025

Comparing institutional holders between quarters

Quarters

Q4 2025Q3 2025Q2 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Pacer Advisors, Inc.
INCREASED
Shares75,000 from 64,000
Change+11,000 (+17%)
Value$77.7K (+$11.8K)
Filed 2026-02-24
Status
Pacer Advisors, Inc.
INCREASED75,00064,000+11,000+17%$66.0K$77.7K+$11.8K2026-02-24
Showing 1 of 1 institutions